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Outcome of Pregnancy
in Women With Congenital Heart Disease
A Literature Review
Willem Drenthen, MD,* Petronella G. Pieper, MD, PHD,* Jolien W. Roos-Hesselink, MD, PHD,‡
Willem A. van Lottum, MD,* Adriaan A. Voors, MD, PHD,* Barbara J. M. Mulder, MD, PHD,§
Arie P. J. van Dijk, MD, PHD, Hubert W. Vliegen, MD, PHD,¶ Sing C. Yap, MD,‡
Philip Moons, PHD, RN,# Tjark Ebels, MD, PHD,† Dirk J. van Veldhuisen, MD, PHD, FACC,*
on behalf of the ZAHARA Investigators
Groningen, Rotterdam, Amsterdam, Nijmegen, and Leiden, the Netherlands; and Leuven, Belgium
A search of peer-reviewed literature was conducted to identify reports that provide data on complications associ-
ated with pregnancy in women with structural congenital heart disease (CHD). This review describes the out-
come of 2,491 pregnancies, including 377 miscarriages (15%) and 114 elective abortions (5%). Important car-
diac complications were seen in 11% of the pregnancies. Obstetric complications do not appear to be more
prevalent. In complex CHD, premature delivery rates are high, and more children are small for gestational age.
The offspring mortality was high throughout the spectrum and was related to the relatively high rate of prema-
ture delivery and recurrence of CHD. (J Am Coll Cardiol 2007;49:2303–11) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.03.027M
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(rogress in the fields of diagnostic techniques and surgical
ntervention has dramatically improved long-term outcome
n congenital heart disease (CHD). As a consequence, most
atients with congenital cardiac malformations reach child-
earing age, and many of these women wish to become
regnant. Pregnancy itself is a circulatory burden, primarily
ecause of volume loading, which has a significant impact
ven on a healthy woman’s life. In the face of residual lesions
r sequelae after correction or an uncorrected maternal
ongenital heart defect, this burden may have deleterious
ffects on the health of both the mother and her offspring.
To provide an accurate and contemporary overview of the
ardiac, obstetric, and neonatal complications during preg-
ancies in women with CHD, a literature review was
onducted.
rom the *Department of Cardiology and the †Department of Thoracic Surgery,
niversity Medical Center Groningen, Groningen, the Netherlands; ‡Department of
ardiology, Erasmus Medical Centre, Rotterdam, the Netherlands; §Department of
ardiology, Academic Medical Centre, Amsterdam, the Netherlands; Department
f Cardiology, Radboud University Nijmegen Medical Centre, Nijmegen, the
etherlands; ¶Department of Cardiology, Leiden University Medical Centre, Lei-
en, the Netherlands; and #Department of Cardiology, University Hospitals Leuven,
euven, Belgium. Supported by Netherlands Heart Foundation Grant 2002 B125 to
r. Pieper and by the Interuniversity Cardiology Institute, the Netherlands (ICIN).
r. van Veldhuisen is an established investigator for the Netherlands Heart
oundation (grant D97.017).p
Manuscript received December 21, 2006; revised manuscript received February 27,
007, accepted March 13, 2007.ethods
systematic search of peer-reviewed literature using
ubMed, MEDLINE, and the Cochrane Library databases
as performed. Predefined limits were: 1) date of publica-
ion after January 1, 1985, for reasons of contemporaneous
pplicability; 2) the main body of text of the manuscript
eeded to be in English, German, or French to reduce
isinterpretation; 3) the complications reported (in the
ethods or the results section) needed to be traceable to the
atient’s primary CHD; 4) the number of completed (not
borted or miscarried) pregnancies for the primary CHD
ategory needed to be available; and 5) reviews and case
eports describing 1 completed pregnancy were excluded.
he search was performed separately by two independent
esearchers (W.D. and W.A.vL.).
For the present review, the baseline primary CHD and
he number of completed pregnancies, miscarriages, and
herapeutic abortions were recorded. In addition, the fol-
owing complications were recorded for each completed
regnancy. Cardiac complications: reported clinically signifi-
ant (“requiring treatment”) episodes of arrhythmias (in-
luding origin and type of arrhythmia) or heart failure,
ardiovascular events (myocardial infarction, cardiovascular
ortality and/or cerebrovascular accidents), or endocarditis
including first 6 months postpartum). Obstetric complications:
regnancy-induced hypertension, preeclampsia, eclampsia,
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Pregnancy in Women With CHD June 19, 2007:2303–11hemolysis elevated liver enzymes
low platelets (HELLP) syndrome,
thromboembolic events (con-
firmed deep venous thrombosis or
pulmonary embolus), premature
rupture of membranes; premature
labor (37 weeks gestation), post-
partum hemorrhage. Offspring
complications: premature birth (de-
livery 37 weeks), small-for-
gestational-age (SGA) birth weight
(10th percentile), fetal demise
(intrauterine death 20 weeks of
gestation), and/or perinatal mor-
tality (death within the first year of
life).
The query consisted of: congen-
ital heart disease (CHD, atrial sep-
tal defect, atrioventricular septal
defect [AVSD], ventricular septal
defect, aortic stenosis, aortic coarc-
tation, pulmonary valve stenosis
PS], pulmonary atresia, tetralogy of Fallot [TOF], transposi-
ion of the great arteries/vessels [TGA], Ebstein’s, cyanotic
eart disease, Eisenmenger, and Fontan) followed by: AND
pregnancy OR delivery). Abstracts of the identified articles
ere read on the basis of this information and the eligible
rticles were identified. Subsequently, full-text papers were
rdered or downloaded. If a report could not be ordered
hrough our library, attempts were made to contact the
uthors. Additional reports were found through cross-reading
he reference lists of the eligible articles. The available reports
ere independently read by 2 researchers (Dr. Drenthen and
r. van Lottum) and classified according to the defined
riteria. When discrepancies between the 2 researchers were
iscovered, a third independent adult congenital cardiologist
as asked to interpret the data. This third party then decided
ow the data should be interpreted. Efforts were made to filter
ut duplicates; publications from the same institution were
hecked for the period of data collection. The format of the
eview was structured and analyses were performed according
o the Cochrane guidelines.
esults
he literature search was performed between November 1,
005, and October 1, 2006. Searching the Cochrane Library
atabase, we found no reviews. Systematic literature search
f PubMed and MEDLINE retrieved 48 different, mainly
etrospective, publications describing 2,491 pregnancies,
ncluding 377 miscarriages (15%) and 114 (5%) elective
bortions (1–48). It proved impossible to subdivide com-
lications based on surgical status before pregnancy for
very CHD category separately. Patients with TGA had
ndergone atrial correction before pregnancy, except for 3
Abbreviations
and Acronyms
AVSD  atrioventricular
septal defect(s)
CHD  congenital heart
disease
CoA  aortic coarctation
HELLP  hemolysis
elevated liver enzymes low
platelets
PAVSD  pulmonary
atresia with ventricular
septal defects
PS  pulmonary valve
stenosis
SGA  small for
gestational age
TGA  complete
transposition of the great
arteries
TOF  tetralogy of Fallotrterial switch patients. All patients with TOF had under- lone definitive repair. All pulmonary atresia with ventricular
eptal defects (PAVSD) patients had received biventricular
epair. The remaining uncorrected or palliated TGA, TOF,
nd PAVSD patients were incorporated in the category
palliated or uncorrected) of cyanotic heart disease. The
ther CHD cohorts contained a mix of corrected and
ncorrected patients.
Figure 1 provides an overview of the distribution of
estations (completed, miscarriage, and elective abortions)
er CHD. Figure 2 shows the occurrence of the most
mportant cardiac, obstetric, and offspring complications
ecorded in the reviewed literature during completed (not
borted or miscarried) pregnancies organized per CHD.
ables 1 through 3 provide detailed information on each
omplication.
The most frequently encountered cardiac complication
Table 1) was clinically significant heart failure (4.8%).
atients with complex CHD (Eisenmenger, other cyanotic
eart disease, and PAVSD) appeared to be at special risk.
rrhythmias complicated 70 (4.5%) of the completed preg-
ancies. Most of the arrhythmias were supraventricular
achyarrhythmias (n  48). Ventricular tachyarrhythmias
ere reported in 9 patients, bradyarrhythmias in 3 patients,
nd Wolff-Parkinson-White syndrome in 1 patient; in 9
regnancies the exact nature of the arrhythmia was not
eported. Cardiovascular events (myocardial infarction,
troke, and cardiovascular mortality) were documented pri-
arily in Eisenmenger patients and those with palliated or
ncorrected cyanotic heart disease.
Obstetric complications (Table 2) were less well docu-
ented. In general, hypertensive disorders related to preg-
ancy do not appear to be more prevalent for the whole
HD cohort. Eclampsia and HELLP syndrome were
eported in 3 (PS [n  2] and PAVSD [n  1]) and 2
PAVSD and TGA), respectively, of the 904 completed
regnancies (not depicted in Table 2). Especially notewor-
hy, the incidence of preeclampsia and eclampsia in patients
ith TGA, PS, aortic coarctation, and PAVSD exceeded
he expected rate of 2% to 3%. Thromboembolic events,
redominantly pulmonary embolisms, were observed in
pproximately 2% of the pregnancies.
Fetal complications (Table 3) were incorporated more
requently in the methodology of the reviewed articles.
mportantly, overall offspring mortality was 4%, which
ould at least in part be attributed to the relatively high
verall premature birth rate (16%) and the recurrence of
HD. The recurrence rate depended on the type of CHD
nd ranged between 0.6% (TGA) and 8% (AVSD).
iscussion
he present systematic review described the outcome of
,491 pregnancies in women with different types of CHD.
ost pregnancies were successful, though complications
ere observed. Arrhythmias, heart failure, and cardiovascu-
ar events, rarely seen in the healthy general population,
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June 19, 2007:2303–11 Pregnancy in Women With CHDere documented during 11% of completed pregnancies.
bstetric complications, on the other hand, did not appear
o be more prevalent, except for hypertensive disorders and
hromboembolic events. Offspring mortality was high (4%
s. 1% in the general population), and occurred particu-
arly in CHD cohorts with high rates of premature delivery
nd/or recurrence of CHD.
Supraventricular and ventricular arrhythmias requiring
reatment are rarely seen during pregnancy in healthy
omen (49,50). Potential factors that promote the devel-
pment of arrhythmias are the additional circulatory burden
f pregnancy and local electrophysiologic effects, more
pecifically the extra volume load and the enhanced adren-
rgic receptor excitability mediated by estrogens and pro-
esterone (51,52). Structural cardiac defects or residual
efects after repair may contribute to the occurrence of
linically relevant arrhythmias. Most recorded arrhythmias
ere supraventricular in origin. In particular, patients with
GA, Fontan repair, and atrioventricular septal defects
ppeared at risk. Surgical scar tissue formation may play a
ole in the pathophysiologic mechanism. In the TGA
opulation, most patients had undergone atrial repair (Mus-
ard or Senning) with baffle formation. Patients after Fon-
Figure 1 Pregnancy Outcome in Women With Congenital Heart
Distribution of miscarriages, completed pregnancies, and elective abortions for ea
side, the expected rates in healthy women are depicted. AOS  aortic stenosis; A
corrected transposition of the great arteries; CoA  aortic coarctation; Ebstein 
Fontan repair; PAVSD  pulmonary atresia with ventricular septal defects; PS  p
tetralogy of Fallot; VSD  ventricular septal defect.an repair, especially after atriopulmonary anastomosis and ptrioventricular connection, were at risk for atrial tachyar-
hythmias owing to the exposure of right atrial tissue to
igher than normal pressures. In patients with AVSD,
acro–re-entrant tachycardias are well-known complica-
ions after repair and, in addition, (residual) left atrioven-
ricular regurgitation may play a role in the development of
rrhythmias.
In the healthy general population, heart failure needing
edical intervention is uncommon and mainly related to the
evelopment of peripartum cardiomyopathy (53). In our
eview, patients with complex CHD (in particular, patients
ith cyanotic heart disease, Eisenmenger syndrome, and
AVSD) appeared prone to develop heart failure. Overall,
linically significant (“needing medical intervention”) heart
ailure was observed in almost 5% of the completed preg-
ancies. Most episodes resolved without sequelae using
edication. It needs to be said, however, that the given
eart failure rate may be an underestimation, considering
hat early heart failure was an important reason for elective
bortion.
Cardiovascular events (myocardial infarction, cerebrovas-
ular accidents, and mortality) are observed during 1 of
very 50 pregnancies. Mortality was particularly high in
ase
genital heart disease are shown separately and as overall rates. On the right
atrial septal defect; AVSD  atrioventricular septal defects; CC-TGA  congenital
n’s anomaly; Eisenmenger  Eisenmenger syndrome; Fontan  patients after
ry valve stenosis; TGA  complete transposition of the great arteries; TOF Dise
ch con
SD 
Ebstei
ulmonaatients with Eisenmenger syndrome. Therefore, we still
2306 Drenthen et al. JACC Vol. 49, No. 24, 2007
Pregnancy in Women With CHD June 19, 2007:2303–11Figure 2 Distribution of Complications During Pregnancy in Women With CHD
Overview of the most important complications encountered during pregnancy in women with structural congenital heart disease (CHD) for each CHD separately and the
overall rates. On the right side, the expected rates in healthy women are depicted. SGA  small for gestational age; TEC  thromboembolic complications; other abbre-
viations as in Figure 1.
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June 19, 2007:2303–11 Pregnancy in Women With CHDdvocate that pregnancy should be discouraged in these
atients. It needs to be taken into account, however, that
ortality is likely to be underestimated, as most research is
erformed in retrospective or so-called survivor cohorts.
herefore, we have not described mortality as a separate
omplication. For accurate estimations of serious and rela-
ively rare complications a large-scale (multicenter and
nternational) prospective registration remains necessary.
With regard to the occurrence of endocarditis, it is
triking that patients with simple secundum atrial septal
efect appear to be at greater risk. Details on the site of
nfection, the causative organism, and circumstances includ-
ng the presence of concomitant minor (anatomic or phys-
ologic) abnormalities that may increase the risk of endo-
arditis are not described. This area needs to be further
nvestigated.
Pregnancy-related hypertensive disorders were docu-
ented in 8.7% of the pregnancies, which is comparable to
he 8% found in the general population (54). In four CHD
ategories, however, the incidence of hypertensive disorders
ppears substantially higher. In patients with aortic stenosis,
S, aortic coarctation, and TGA, hypertensive disorders
ccurred in respectively 12.8%, 14.3%, 16.0%, and 16.3% of
ompleted pregnancies. Preeclampsia is a relatively rare
ondition with a reported incidence in the developed coun-
ries between 2% and 3%; eclampsia is even rarer, with
stimated incidences of 4 to 5 cases per 10,000 live births.
oth entities are generally associated with substantial ma-
ernal and neonatal morbidity (55,56). Preeclampsia ap-
eared to cluster in patients with aortic coarctation, PS,
verview of Cardiac Complications Encountered During Completedummarized and Sorted by Maternal Primary Cardiac Diagnosis for
Table 1 Overview of Cardiac Complications Encountered DuringSummarized and Sorted by Maternal Primary Cardiac D
Arrhythmias
Congenital Heart Disease (Ref. no.)
Events,
n (%)
Pregnancies,
n
E
ASD (1,20,27,33,45) 1 (0.8) 123
VSD (20,27,33,45) 0 (0.0) 66
AVSD (13,45) 9 (10.2) 88
PS (17,27,33,35,36,48) 0 (0.0) 100
Ebstein (9,10,20,27,35,36) 5 (3.9) 127
AOS (14,17,20,21,27,28,33–36) 4 (2.4) 168 1
CoA (3,20,27,29,32,33,35,36,41–43) 0 (0.0) 297
CC-TGA (8,20,36,39) 3 (3.6) 84
TGA (6,12,15,16,20,22–24,27,33,35,36,47) 27 (15.6) 173 1
TOF (20,25,27,33,35,36,40,45) 13 (6.4) 204
PAVSD (7,26,46) 1 (2.5) 40
Fontan (4,5,11,18) 4 (16.0) 25
Cyanotic CHD (30,31,33,35) 3 (4.8) 63 1
Eisenmenger (2,19,27,29,37,38,44) 0 (0.0) 4
Overall 70 (4.5) 1,562 7
Expected occurrence (%) 0.5
Expressed as number of complications/completed pregnancy (percentage per completed pregna
AOS aortic stenosis; ASD atrial septal defect; AVSD atrioventricular septal defects; CC-TGA
oarctation; Ebstein Ebstein’s anomaly; Eisenmenger Eisenmenger syndrome; Fontan patien
tenosis; TGA  complete transposition of the great arteries; TOF  tetralogy of Fallot; VSD  veAVSD, and TGA. Several mechanisms, either solitary or mombined, may be hypothesized. First, activation of neuro-
ormonal pathways in patients with CHD may alter
ascular remodeling associated with pregnancy-induced
ypertension and (pre-)eclampsia. Second, endothelial
ysfunction is present in patients with CHD. Finally,
xidative stress may interact with the pathophysiologic
echanisms behind pregnancy-induced hypertension and
pre-)eclampsia.
During pregnancy and the postpartum period, patients
re at risk for thromboembolic complications owing to the
resence of all three components of Virchow’s triad: venous
tasis, endothelial injury, and a hypercoagulable state. Nev-
rtheless, thromboembolic events are normally seen only
nce per 1,000 to 2,000 pregnancies (57,58). Fifteen throm-
oembolic complications occurred, which suggests that the
ncidence in women with CHD (1:50) is substantially
ncreased compared with the general population. Impor-
antly, associated disorders, such as the presence of inherited
hrombophilia, malignancy, systemic disease, recent surgery
r trauma, disease needing hormonal replacement therapy,
r bone marrow diseases, were insufficiently documented.
his finding merits further investigation.
Premature birth rate (16%) also appeared higher than
enerally reported in the industrialized world (10% to 12%).
n patients with more complex CHD, including Ebstein,
GA, PAVSD, Fontan, cyanotic CHD, and Eisenmenger,
he preterm delivering rates ranged between 22% and 65%.
remature labor seems to play an important role in the
igher incidence of premature birth in these CHD catego-
ies. Several premature deliveries were iatrogenic, which
Weeks Gestation) Pregnanciesles Published Between 1985 and 2006*
pleted (>20 Weeks Gestation) Pregnancies
osis for Articles Published Between 1985 and 2006*
eart Failure Cardiovascular Events Endocarditis
, Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
132 2 (1.3) 149 1 (3.8) 26
74 1 (1.2) 83 0 (0.0) 17
88 0 (0.0) 88 0 (0.0) 48
110 0 (0.0) 123 0 (0.0) 102
127 0 (0.0) 128 0 (0.0) 127
200 5 (2.5) 200 1 (0.6) 175
303 1 (0.3) 304 0 (0.0) 303
84 2 (2.4) 84 1 (1.2) 84
) 176 4 (2.2) 178 0 (0.0) 178
211 0 (0.0) 222 1 (0.6) 174
) 40 1 (2.5) 40 0 (0.0) 40
25 0 (0.0) 25 0 (0.0) 25
) 74 3 (4.1) 74 3 (4.1) 74
) 19 14 (33.3) 42 0 (0.0) 2
1,663 33 (1.9) 1,740 7 (0.5) 1,372
0.5 0.01
genital corrected transposition of the great arteries; CHD congenital heart disease; CoA aortic
r Fontan repair; PAVSD pulmonary atresia with ventricular septal defects; PS pulmonary valve
r septal defect.(>20Artic
Com
iagn
H
vents
n (%)
0 (0.0)
0 (0.0)
1 (1.1)
0 (0.0)
4 (3.1)
4 (7.0)
3 (1.0)
6 (7.1)
9 (10.8
5 (2.4)
8 (20.0
1 (4.0)
4 (18.9
4 (21.1
9 (4.8)
0.5
ncy).
 conay imply a greater tendency of the attending gynecologist
Overview of Pregnancy/Obstetric Complications Encountered During Completed (>20 Weeks Gestation)Pregnancies Summarized and Sorted by M ernal Primary Cardiac Diagnosis for Articles Publish d Between 1985 and 2006*
Table 2 Overview of Pregnancy/Obstetric Complications Encountered During Completed (>20 Weeks Gestation)Pregnancies Summarized and Sorted by Maternal Primary Cardiac Diagnosis for Articles Published Between 1985 and 2006*
PIH Preeclampsia TEC PROM Premature Labor PPH
Congenital Heart Disease (Ref. no.)
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
ASD (1,20,27,33,45) 0 (0.0) 93 3 (0.8) 248 1 (5.0) 20 NA NA NA NA 0 (0.0) 9
VSD (20,27,33,45) 1 (1.5) 65 1 (1.8) 57 1 (1.8) 57 NA NA NA NA 0 (0.0) 8
AVSD (13,45) 7 (8.0) 88 2 (2.3) 88 0 (0.0) 88 0 (0.0) 48 3 (6.3) 48 10 (20.8) 48
PS (17,27,33,35,36,48) 7 (7.7) 91 4 (4.9) 81 2 (2.5) 81 5 (6.2) 81 11 (13.5) 81 13 (14.3) 91
Ebstein (9,10,20,27,35,36) NA NA NA NA NA NA NA NA 4 (11.1) 36 NA NA
AOS (14,17,20,21,27,28,33–36) 5 (12.8) 39 0 (0.0) 20 0 (0.0) 20 0 (0.0) 20 1 (4.2) 24 1 (2.2) 45
CoA (3,20,27,29,32,33,35,36,41–43) 27 (11.1) 244 12 (4.9) 245 0 (0.0) 33 0 (0.0) 132 0 (0.0) 132 0 (0.0) 139
CC-TGA (8,20,36,39) 1 (2.0) 50 1 (2.0) 50 1 (3.7) 27 NA NA NA NA NA NA
TGA (6,12,15,16,20,22–24,27,33,35,36,47) 5 (8.3) 80 8 (10.3) 78 2 (3.0) 66 10 (17.5) 57 18 (29.0) 62 9 (13.8) 65
TOF (20,25,27,33,35,36,40,45) 0 (0.0) 176 3 (1.8) 169 1 (0.6) 169 1 (0.8) 132 NA NA 5 (8.8) 57
PAVSD (7,26,46) 0 (0.0) 17 1 (5.9) 17 2 (6.7) 30 0 (0.0) 7 5 (29.4) 17 0 (0.0) 7
Fontan (4,5,11,18) 1 (4.0) 25 0 (0.0) 25 0 (0.0) 25 4 (16.0) 25 3 (12.0) 25 2 (8.0) 25
Cyanotic CHD (30,31,33,35) 0 (0.0) 21 0 (0.0) 9 2 (3.6) 56 0 (0.0) 9 2 (22.2) 9 2 (9.5) 21
Eisenmenger (2,19,27,29,37,38,44) NA NA 0 (0.0) 11 3 (18.8) 16 0 (0.0) 1 3 (15.8) 19 2 (28.6) 7
Overall 54 (5.5) 989 35 (3.2) 1,098 15 (2.2) 688 20 (3.9) 512 50 (11.0) 453 44 (8.4) 522
Expected occurrence (%) 5.0 2.0–3.0 0.1 3.5 10.0–12.0 Not known
*Expressed as number of complications/completed pregnancy (percentage per completed pregnancy).
PIH  pregnancy-induced hypertension; PPH  postpartum hemorrhage; PROM  premature rupture of membranes; TEC  thromboembolic complications; other abbreviations as in Table 1.
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Overview of Offspring Complications Encountered During Completed (>20 Weeks Gestation) PregnanciesSummarized and Sorted by Primary Maternal Cardiac Diagnosis for Articles Published Between 1985 and 2006*
Table 3 Overview of Offspring Complications Encountered During Completed (>20 Weeks Gestation) PregnanciesSummarized and Sorted by Primary Maternal Cardiac Diagnosis for Articles Published Between 1985 and 2006*
Premature Delivery SGA Fetal Mortality Perinatal Mortality CHD Recurrence
Congenital Heart Disease (Ref. no.)
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
Events,
n (%)
Pregnancies,
n
ASD (1,20,27,33,45) 10 (6.0) 168 5 (1.8) 274 7 (2.4) 291 5 (1.7) 291 6 (2.1) 291
VSD (20,27,33,45) 2 (11.8) 17 1 (1.4) 74 1 (1.4) 74 0 (0.0) 74 2 (2.7) 74
AVSD (13,45) 3 (6.3) 48 7 (8.0) 88 1 (1.1) 88 2 (2.3) 88 7 (8.0) 88
PS (17,27,33,35,36,48) 16 (14.5) 110 11 (10.0) 110 1 (0.8) 123 5 (4.1) 123 3 (2.8) 104
Ebstein (9,10,20,27,35,36) 28 (22.0) 127 5 (11.9) 42 0 (0.0) 128 3 (2.3) 128 5 (4.0) 126
AOS (14,17,20,21,27,28,33–36) 12 (8.3) 145 8 (5.5) 145 0 (0.0) 158 1 (0.6) 158 5 (4.1) 121
CoA (3,20,27,29,32,33,35,36,41–43) 20 (7.9) 253 7 (3.1) 224 0 (0.0) 254 6 (2.4) 254 10 (4.0) 251
CC-TGA (8,20,36,39) 7 (9.0) 78 0 (0.0) 28 1 (1.3) 78 0 (0.0) 78 1 (3.6) 28
TGA (6,12,15,16,20,22–24,27,33,35,36,47) 43 (34.1) 126 18 (19.0) 95 5 (2.8) 179 2 (1.1) 179 1 (0.6) 176
TOF (20,25,27,33,35,38,40,45) 11 (6.3) 174 19 (9.0) 211 1 (0.5) 222 3 (1.4) 222 6 (3.0) 202
PAVSD (7,26,46) 13 (32.5) 40 6 (20.0) 30 1 (2.5) 40 4 (10.0) 40 3 (7.5) 40
Fontan (4,5,11,18) 7 (28.0) 25 3 (12.0) 25 0 (0.0) 25 1 (4.0) 25 1 (4.0) 25
Cyanotic CHD (30,31,33–35) 33 (44.6) 74 18 (66.7) 27 9 (12.2) 74 3 (4.1) 74 5 (7.4) 68
Eisenmenger (2,19,27,29,37,38,44) 22 (64.7) 34 3 (37.5) 8 4 (9.5) 42 4 (18.2) 22 1 (5.0) 20
Overall 224 (15.9) 1,413 110 (8.0) 1,381 31 (1.7) 1,776 41 (2.3) 1,756 56 (3.5) 1,616
Expected occurrence (%) 10.0–12.0 10.0 0.5 0.5 NA
*Expressed as number of complications/completed pregnancy (percentage per completed pregnancy).
SGA  small for gestational age; other abbreviations as in Table 1.
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Pregnancy in Women With CHD June 19, 2007:2303–11o intervene in women with CHD. A high incidence of
remature rupture of membranes may have played a role in
atients with TGA and Fontan. Spontaneous premature
eliveries occurred frequently before 34 weeks of gestation,
hich has important clinical repercussions.
Small-for-gestational-age children were documented
n the same types of CHD as premature delivery, except
or patients with Fontan repair. In Fontan, premature
eliveries could be attributed mainly to the excessive
ccurrence of premature rupture of membranes. In the
ther types of CHD, a similar pathophysiologic mecha-
ism may explain the higher incidence of premature
elivery, as well as the SGA children. In both complica-
ions, placental insufficiency plays a pivotal role. Investi-
ation of the fetal-placental circulation in these women is
ecessary.
An important finding of the present systematic review is
hat children of women with CHD are at higher risk for
etal and perinatal mortality. In the industrialized world,
etal and perinatal mortality is below 1%. Therefore, the
hance of offspring mortality is on average increased by 4
imes. Importantly, in the types of CHD with high rates of
remature delivery and/or CHD recurrence, this risk was
ore profound, ranging up to 27.7% in women with
isenmenger syndrome. The recurrence risks are in agree-
ent with the larger genetic cohort studies.
Several limitations of the present systematic review
eed to be discussed. The quality of the review depends
n the design of the articles included. The study designs
anged from prospectively included cohort studies to case
eries reporting 2 completed pregnancies; therefore, the
esults need to be judged with caution. Moreover, pub-
ication bias is an important factor, especially in case
eries. Selection bias is introduced by excluding articles
ased on earlier-mentioned criteria. Underreporting of
omplications may also be an important problem.
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